Phaeochromocytoma and paraganglioma (Q40905092)

24 September 2017

1 reference

title

Phaeochromocytoma and paraganglioma (English)

1 reference

24 September 2017

Fonseca V

1

1 reference

24 September 2017

Bouloux PM

series ordinal

2

1 reference

24 September 2017

publication date

1 April 1993

1 reference

Bailliere's clinical endocrinology and metabolism

24 September 2017

published in

1 reference

24 September 2017

volume

7

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

509-544

1 reference

Role of venous sampling in locating a phaeochromocytoma.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Paroxysmal hypertension with concomitant swelling of the thyroid due to pheochromocytoma of the right adrenal gland; cure by surgical removal of the pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Unsuspected phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Acute hypertension mimicking phaeochromocytoma as main presenting feature of acute intermittent porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Simultaneous assay of noradrenaline and its deaminated metabolite, dihydroxyphenylglycol, in plasma: a simplified approach to the exclusion of phaeochromocytoma in patients with borderline elevation of plasma noradrenaline concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Pheochromocytoma: postoperative shock and blood volume

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Is paroxysmal thyroid swelling due to phaeochromocytoma a forgotten physical sign?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

HALOTHANE ANESTHESIA AND CATECHOLAMINE LEVELS IN A PATIENT WITH PHEOCHROMOCYTOMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Phaeochromocytoma of the spermatic cord: Report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Pheochromocytoma with pyrexia and marked inflammatory signs: a paraneoplastic syndrome with possible relation to interleukin-6 production

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Insulin-like growth factor-II: possible local growth factor in pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

ORG NC45 (Norcuron) and pheochromocytoma: a report of three cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Successful control of pheochromocytoma in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Normalization of left ventricular ejection fraction following resection of pheochromocytoma in a patient with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Von Hippel-Lindau Disease with multiple manifestations: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Phaeochromocytoma, neurofibromatosis and pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Pheochromocytoma in the adult and in the child

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Severe hypertension associated with pancuronium in a patient with a phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

1 reference

7 January 2021

Pseudopheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Intraoperative localization of malignant pheochromocytoma by 123-I-metaiodobenzylguanidine single probe measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Biochemical screening for pheochromocytoma. Superiority of urinary metanephrines measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Deletion of genes on chromosome 1 in endocrine neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Adrenal pheochromocytoma: a clinicopathologic review of 60 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Cardiac complications of phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Pheochromocytoma with predominant epinephrine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Preoperative acute volume loading in patients with pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

False positive diagnosis of phaeochromocytoma in a patient with Parkinson's disease receiving levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Cardiovascular complications of pheochromocytoma crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Preoperative and operative management of patients with phaeochromocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Watery diarrhea syndrome due to an adrenal pheochromocytoma secreting vasoactive intestinal polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Pheochromocytoma and pregnancy. Review of 89 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Phaeochromocytoma and pregnancy--an updated appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Localization of ectopic pheochromocytomas by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Pheochromocytoma, polycythemia, and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Cardiac arrhythmias and cardiomyopathy associated with pheochromocytomas. Report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

PHEOCHROMOCYTOMA IN CHILDREN. REPORT OF 9 CASE AND REVIEW OF THE FIRST 100 PUBLISHED CASES WITH FOLLOW-UP STUDIES.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Two forms of parathyroid hormone-like adenylate cyclase-stimulating protein derived from tumors associated with humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Interleukin-6-Producing Pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Adrenal pheochromocytoma simulating diabetes insipidus; report of a case and review of the other pediatric cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

The neurologist's experience with pheochromocytoma. A review of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Therapeutic embolization of phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

A re-evaluation of dopamine excretion in phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Phaeochromocytoma as a cause of reversible dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980186-7

7 January 2021

10.1016/S0950-351X(05)80186-7

Identifiers

DOI

1 reference

24 September 2017

1 reference